“showed a trend”

The absence of calcification showed a trend toward greater VAS improvement (β = −0.43; p = 0.105).

End‐of‐treatment MRD negativity showed a trend towards association with a better ORR (100% vs. 69%, p = 0.105) and CR rate (90% vs. 54%, p = 0.062; Table S9 ), a trend towards association with improved PFS (2‐year PFS 90% vs. 46%, HR 0.26, 95% CI 0.07–0.95, p = 0.065), and was significantly associated with a better OS (2‐year OS 100% vs. 69%, HR 0.15, 95% CI 0.03–0.85, p = 0.031; Figure 6C,D ).

There was no group effect following intervention in an ancova model considering positive and negative vigilance simultaneously, however, simple effects contrasts of group responses to negative and positive vigilance separately showed a trend towards a reduction in negative vigilance following intervention in the GOS group compared to placebo group (β -30.75 ms, SE = 18.58, p =.105), Fig. 3 B.

A post hoc analysis showed a trend toward a treatment difference (−253 g/week [−563; 58] P = .105).

Although there were no statistical differences, Kaplan-Meier analyses showed a trend that RFS in patients with high serum FGF19 levels (≥200 pg/mL) is shorter than those in patients with low serum FGF19 levels ( p = 0.106, Fig. 5 a).

While not reaching statistical significance, individuals with acute COVID-19 showed a trend toward greater IMT increases (0.19 mm, 95% CI: 0.06–0.69) compared to those with non-acute disease (0.10 mm, 95% CI: 0.06–0.13, and p = 0.106).

The risk of POAF observed in the late postoperative period showed a trend toward increased risk that did not reach statistical significance (HR 1.25, 95% CI 0.95–1.64, p=0.106).

Meta-regression showed a trend for greater DBP reduction with higher pretreatment DBP ( P = 0.106) ( Figure 2B ).

In the SRR cohort, sotrovimab showed a trend toward lower outcome risk than molnupiravir [HR 0.39 (95% CI 0.13–1.21); P = .106].

The ZNS-treated α1β2γ2/γ2(Q390X) + pcDNA condition (ZNS) showed a trend towards an increase (0.572 ± 0.017), but this was not statistically different from Q390X ( p = 0.106) and was still lower than WT ( p < 0.0001) ( Figure 3 A,D).

Daily mean leptin concentration showed a trend towards a moderately correlated positive linear relationship with rumen temperature ( p = 0.106, r = 0.613) for the FRTN group only (Fig. 5 E).

The latter showed a trend toward less edema (p = 0.106, Jonckheere-Terpstra) in patients >65 ys.

Upon progressive disease, 20 patients (30.8%) received subsequent chemotherapy, and showed a trend for longer median overall survival (OS) than in those receiving a non-chemotherapy regimen (25.0 vs. 11.8 months, p = 0.106).

For TP53 wt CK-AML, STAT3 inhibitor (S31-201) was the only potent compound that showed a trend towards sensitivity ( P = 0.106) (Fig. 1B ).

Similarly, a history of hallucinations or psychosis showed a trend in the same direction (11/19 [57.9%] vs. 5/17 [29.4%], p =0.106).

Importantly, most physiological, functional, and psychological parameters showed no statistically significant baseline differences (all P>0.05); however, the intervention group showed a trend toward better baseline upper limb muscle tone scores (P = 0.106), suggesting a possible selection bias in patients with better functional status in the intervention group.

Hearts with TGA and Ebstein, although not reaching statistical significance, showed a trend to an increased risk of LVNC (TGA: p = 0.1064; OR 6.93; 95CI 0.38–126.1; Ebstein: p = 0.0711; OR 27.09; 95CI 0.49–189.2) when analyzed by Chin’s method. 3.5.

A Glasgow coma scale (GCS) of more than 3 showed a trend ( p =0.1065) toward a better motor functional outcome.

Indeed, the thickening fraction during tidal breathing showed a trend towards increased values during true acupuncture (43.5 ± 16.6%) vs. sham (31.3 ± 14.9%) and baseline (30.8 ± 15.3%), p =0.1066.

Combination of surgery and chemotherapy showed a trend towards higher overall survival in non-metastatic patients (p = 0.1069 and p = 0.1703).

L-centres showed a trend towards superior R1 rate (CRM+ and/or DRM+) with 4.4% versus 8.7% in R-centres and 8.4% in Ta-centres, P = 0.107.

However, the T-αFGL2 cells showed a trend toward enrichment in core T RM genes when compared with T-Ctr cells (Supplementary Fig. 8f , NES = 1.23, P = 0.107), suggesting that T-αFGL2 treatment does not directly transform regular T cells into brain tumor–specific T RM cells.

Perfusate potassium levels showed a trend towards an increase in the banked blood group (5.4 versus 7.6 mmol/L; P = 0.107); there were no differences in sodium (142.0 versus 143.9 mmol/L; P = 0.404) and bicarbonate (13.0 versus 14.3 mmol/L; P = 0.491) concentrations.

However, although patients with a postoperative CCL23 level above the ideal cut-off value showed a trend towards an impaired survival, statistical significance was not reached ( p = 0.107, Figure 4(c) ).

CXCR4 expression significantly increased at recurrence ( p = 0.029), and expression of its ligand CXCL12 showed a trend toward an increase ( p = 0.107).